- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03193268
Effects of Intensity-matched Agility and Cycling Exercise Training on PD Patients' Clinical Symptoms, Posture, and Mobility
Determine the short-term and lasting effects of intensity-matched exercise programs on level 2-3 PD patients' clinical symptoms, postural control, and mobility.
Hypothesis
- The inclusion of a Borg-scale/heart-rate matched active control group will allow us to test the idea that, in addition to a fitness element, the reflexive movements that chellenge PD patients' sensorimotor system will improve patients' clinical symptoms, posture, and mobility more than fitness training and that such lasting effects will be superior in the agility compared with the fitness-control group. This hypothesis emered from the idea that the favorable results in the currently under review paper may be in part due to a simple conditioning effect instead of a specific motor learning effect caused by the xbox training.
- If feasible, i.e., if there is a lerge enough pool of patients to randomize, a balance training group will be also added to test the idea that the reflexive actions evoked by the agility program by xbox exergaming still produce superior adaptations vs. the balance group because xbox forces patients to rapidly and reflexively execute movements (respond to cues, prompts), while balance training allows patients to stop, go, stop, and go and disrupt the continous execution of linked movements. The disruptions of movement chains could arise from small losses of balance on the unstabel surfaces, need for patients to re-initiate every movement element of a sequence, planning each movement element. It is not clear yet how it woul be possible to match all three intervention groups on Borg/heart rate intensity.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Agility: Xbox based high intensity program, as detailed in the submitted manuscript. Borg scale after after each exercise block is recorded. Heart rate continuosly measured. These data are used to set intensity in the fitness group.
Fitness: A stationary bicycle ergometer program that includes visual stimulation in the form of watching nature programs and movies to account for visual stimulus in Agility group. Mean heart rate and Borg scale readings from Agility group will form the target intensity.
Control: No-exercise, measurment-only control group.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Somogy
-
Kaposvár, Somogy, Hungary, 7400
- Somogy Megyei Kaposi Mór Teaching Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Parkinson's disease,
- Hoenh Yahr scale of 2-3,
- instability problem,
Exclusion Criteria:
• Severe heart problems, severe demeanor, alcoholism, drug problems,
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: High intensity agility group
Exercise therapy
|
The groups participate in observation for 5 weeks.
Two groups take part in a motion therapy over the 5-week period.
|
|
Experimental: Non-agility cycling group
Parkinson's Bicycle Group, which takes 1 hour of exercise every day for 5 weeks
|
Patients must undergo a daily exercise cycle of 1 hour during the intervention
|
|
No Intervention: No-exercise control group
Control Parkinson's disease control group thad will not receive exercise treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
EQ5D-5L
Time Frame: 0-5 scale (5 weeks-long, the higher score is better)
|
Questionnaire
|
0-5 scale (5 weeks-long, the higher score is better)
|
|
Borg test
Time Frame: 0-40 point (5 week-long, higher score is better)
|
Fatigue questionnaire
|
0-40 point (5 week-long, higher score is better)
|
|
PDQ-39
Time Frame: 0-39 scale (5week-long, higher score is better)
|
special Parkinson's Disease test - motor and no-motor function
|
0-39 scale (5week-long, higher score is better)
|
|
SPPB test (gait, balance, leg stregth)
Time Frame: 0-12 scale (5 week-long, higher score is better)
|
Walking and balance testing
|
0-12 scale (5 week-long, higher score is better)
|
Collaborators and Investigators
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IKEB0014/2015
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
Bezmialem Vakif UniversityRecruitingParkinson Disease | Parkinson | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseTurkey (Türkiye)
-
CND Life SciencesDigestive Disease Associates of CTRecruitingParkinson Disease | Parkinson | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Neuron23 Inc.Roche Diagnostic Ltd.; Qiagen Manchester LimitedRecruitingParkinson Disease | Parkinson | Idiopathic Parkinson Disease | Parkinson Disease, Idiopathic | Early Parkinson Disease (Early PD)United States, Spain, Israel, Poland, Italy, United Kingdom
-
San Francisco Neurology and Sleep CenterNot yet recruitingPARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Haukeland University HospitalUniversity of Bergen; SPARK NSRecruitingParkinson Disease (PD) | Parkinson s DiseaseNorway
-
CND Life SciencesOregon Health and Science UniversityRecruitingParkinson Disease | Parkinson | Parkinson's Disease and Parkinsonism | PARKINSON DISEASE (Disorder)United States
-
Università degli Studi dell'InsubriaUniversidade Nova de Lisboa; Associazione Parkinson Insubria (AsPI), Section... and other collaboratorsRecruitingParkinson Disease | Parkinson | Parkinson Disease, Idiopathic | PARKINSON DISEASE (Disorder)Italy
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
Duke UniversityMedical University of South Carolina; Massachusetts General Hospital; Mayo Clinic and other collaboratorsNot yet recruitingGut Microbiota | Gut Microbiome | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Prodromal Parkinsons DiseaseUnited States
-
ProgenaBiomeWithdrawnParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
Clinical Trials on Single-blind RTC of PD patients
-
Hamad Medical CorporationCompletedPneumonia | Covid19 | Corona Virus Infection | Cytokine Release Syndrome | Viral InfectionQatar
-
University of ManitobaHoffmann-La RocheTerminatedInfluenza A VirusCanada
-
Manjunath Prakash PaiHoffmann-La RocheCompleted
-
Hospital Universitario Principe de AsturiasHoffmann-La RocheCompleted
-
nurmuhammet tasNot yet recruitingLateral Epicondylitis
-
University of OxfordUniversity College, London; KEMRI-Wellcome Trust Collaborative Research Program and other collaboratorsUnknown
-
University of CopenhagenTechnical University of DenmarkNot yet recruitingBioavailability of Vitamin KDenmark
-
Tamer cebeIstanbul University - Cerrahpasa (IUC)CompletedInvestigation of Myocardial Protection Efficacy of Cardioplegia Solutions Used in Open Heart SurgeryCardiovascular Diseases | Myocardial Reperfusion InjuryTurkey
-
Assistance Publique Hopitaux De MarseilleRecruitingParkinson DiseaseFrance
-
Yu JiakuoCompletedAnterior Cruciate Ligament Injuries